Teneligliptin
Teneligliptin
Teneligliptin (pronounced: ten-uh-li-glip-tin) is an oral antihyperglycemic agent used for the treatment of Type 2 diabetes. It belongs to the class of drugs known as dipeptidyl peptidase-4 inhibitors or DPP-4 inhibitors.
Etymology
The name 'Teneligliptin' is derived from its chemical structure, which contains ten elements, and 'gliptin', a common suffix for DPP-4 inhibitors.
Mechanism of Action
Teneligliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). This enzyme is involved in the inactivation of the incretin hormones GLP-1 and GIP. By inhibiting DPP-4, Teneligliptin increases the levels of these incretin hormones, leading to increased insulin release and decreased glucagon levels. This results in a decrease in blood glucose levels.
Related Terms
- Dipeptidyl peptidase-4 inhibitors: A class of drugs that work by inhibiting the enzyme DPP-4. Other drugs in this class include Sitagliptin, Vildagliptin, and Saxagliptin.
- Antihyperglycemic: A term for drugs used to lower blood glucose levels.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- GLP-1: A hormone that is released in the intestines during a meal. It helps to regulate blood sugar levels.
- GIP: A hormone that works with insulin to lower blood sugar.
See Also
External links
- Medical encyclopedia article on Teneligliptin
- Wikipedia's article - Teneligliptin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski